Newflora SF68®- (drug)
Product description
Drug product for the treatment of infective diarrhea (adult and children), traveler's diarrhea and dysbiosis. Based on proprietary probiotic strain SF68®, with unique characteristics and manufactured under pharmaceuticals GMPs. Its efficacy is supported by more than 20 clinical trials and its safety is confirmed by a recent (2018) publication and by more than 100 million patients treated along 40 years of commercialization.
Registered as drug product in Switzerland (Bioflorin), Austria, Italy and Korea.
Available a full CTD dossier and a CPP (Certificate of Pharmaceutical Product) from Switzerland.
Cerbios is looking for commercial Partners worldwide.
Read more
Registered as drug product in Switzerland (Bioflorin), Austria, Italy and Korea.
Available a full CTD dossier and a CPP (Certificate of Pharmaceutical Product) from Switzerland.
Cerbios is looking for commercial Partners worldwide.
Specifications
Categories | Probiotics |
---|---|
Sales markets | Western Europe; Asia |
Supplied from | Switzerland |
Product Applications | Food Supplements; Pharmaceutical |
Product Certifications | Health & Safety (GMP, HAACP and equivalents) |
More products from Cerbios-Pharma SA
Products from other suppliers
❮
❯
-
[Inner Flora/UREX®] Korea's No.1 Vaginal Probiotics
-
SOLUGEL collagen peptides
-
EMBO CAPS®AP - Acid Protection
-
Fenoprolic® Organic Pine bark extracts
-
Mobilee – the first hyaluronic acid matrix ingredient
-
Retico® - Eye health active support & prevention of eye diseases
-
Naticol® x3Peptide
-
NAD+ (nicotinamide adenine dinucleotide) TEST
-
Collasel Hydrolyzed Collagen Peptide
-
NAMINO® UH
Newflora SF68®- (drug)